Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.190
+0.230 (7.77%)
At close: Oct 11, 2024, 4:00 PM
3.110
-0.080 (-2.51%)
After-hours: Oct 11, 2024, 7:08 PM EDT
Editas Medicine Employees
Editas Medicine had 265 employees as of December 31, 2023. The number of employees increased by 39 or 17.26% compared to the previous year.
Employees
265
Change (1Y)
39
Growth (1Y)
17.26%
Revenue / Employee
$252,958
Profits / Employee
-$730,000
Market Cap
262.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Zynex | 1,100 |
AngioDynamics | 748 |
Poseida Therapeutics | 330 |
Amarin Corporation | 275 |
2seventy bio | 274 |
Biodesix | 217 |
Precigen | 202 |
Compass Therapeutics | 32 |
EDIT News
- 4 days ago - Editas Medicine (EDIT) Shares Plunge Amid Biotech Sector Fluctuations - GuruFocus
- 5 days ago - Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma - Seeking Alpha
- 8 days ago - Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust - GlobeNewsWire
- 10 days ago - Editas Medicine, Inc. (EDIT) Chardan's 8th Annual Genetic Medicines Conference (Transcript) - Seeking Alpha
- 17 days ago - Editas Medicine: A Risk/Reward Worth Considering - Seeking Alpha
- 24 days ago - Editas Medicine, Inc. (EDIT) 2024 Cantor Global Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) - Seeking Alpha